 Connection
David Morrison to Neonatal Screening
This is a "connection" page, showing publications David Morrison has written about Neonatal Screening.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.371 |
|
|
|
-
Quinn GE, Ying GS, Bell EF, Donohue PK, Morrison D, Tomlinson LA, Binenbaum G. Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study. JAMA Ophthalmol. 2018 12 01; 136(12):1383-1389.
Score: 0.125
-
Quinn GE, Ying GS, Repka MX, Siatkowski RM, Hoffman R, Mills MD, Morrison D, Daniel E, Baumritter A, Hildebrand PL, Schron EB, Ells AL, Wade K, Kemper AR. Timely implementation of a retinopathy of prematurity telemedicine system. J AAPOS. 2016 10; 20(5):425-430.e1.
Score: 0.107
-
Cao JH, Wagner BD, Cerda A, McCourt EA, Palestine A, Enzenauer RW, Braverman RS, Wong RK, Tsui I, Gore C, Robbins SL, Puente MA, Kauffman L, Kong L, Morrison DG, Lynch AM. Colorado retinopathy of prematurity model: a multi-institutional validation study. J AAPOS. 2016 06; 20(3):220-5.
Score: 0.105
-
Binenbaum G, Tomlinson LA, de Alba Campomanes AG, Bell EF, Donohue P, Morrison D, Quinn GE, Repka MX, Rogers D, Yang MB, Yu Y, Ying GS. Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria. JAMA Ophthalmol. 2020 01 01; 138(1):31-37.
Score: 0.034
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|